Status:
COMPLETED
COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsors:
Samusocial de Paris
Assistance Publique - Hôpitaux de Paris
Conditions:
SARS-COV2 Infection
Eligibility:
All Genders
18+ years
Brief Summary
Study of COVID-19 seroprevalence in precarious population living in shelters of Samusocial de Paris and in staff working in these centers during COVID-19 epidemic.
Detailed Description
After emergence of a new coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2) responsible for a cluster of respiratory infection at Wuhan, China, on January, 7th 2020, first cases ...
Eligibility Criteria
Inclusion
- to have been hosted or working in one the three centers (LHSS Ridder-Plaisance or Saint Michel or Halte femmes) between march and may 2020
- to be aged 18 y or more
- to be able to give an informed consent
Exclusion
- people who refuse to participate
- not being able to give an informed consent
- Person subject to a legal protection measure (safeguard of justice, curatorship or guardianship)
- Person who does not understand the information provided on how to carry out the research
- Obstacle to venous sampling
Key Trial Info
Start Date :
July 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 22 2021
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT04470648
Start Date
July 22 2020
End Date
August 22 2021
Last Update
December 10 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Haltes pour femmes
Paris, France, 75004
2
LHSS Saint-Michel
Paris, France, 75012
3
LHSS Ridder-Plaisance
Paris, France, 75014